TXG Earnings

Quarterly EPS
$-0.40
Q4 2024
$-0.28
Q1 2025
$0.28
Q2 2025
$-0.22
Q3 2025
$-0.13
Q4 2025
$-0.10
Q1 2026
$-0.14
Q2 2026
$-0.15
Q3 2026
Latest Revenue150.7M
Latest Net Income-19425000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.15150.7M-19425000+1.1%+31.8%
Q2 2026-$0.14151.0M-17931000-12.6%-150.0%
Q1 2026-$0.10150.8M-13470000-2.6%+64.3%
Q4 2025-$0.13166.0M-16252000+0.6%+67.5%
Q3 2025-$0.22149.0M-27472000-1.7%+26.7%
Q2 2025$0.28172.9M34.5M+12.9%+187.5%
Q1 2025-$0.28154.9M-34358000+9.8%+44.0%
Q4 2024-$0.40165.0M-49028000-10.3%+2.4%
Q3 2024-$0.30151.7M-35753000——
Q2 2024-$0.32153.1M-37897000——
Q1 2024-$0.50141.0M-59949000——
Q4 2023-$0.41184.0M-48952000——
10x Genomics (TXG) — Earnings